alexa Measuring quality of life in muscular dystrophy.
Chemistry

Chemistry

Modern Chemistry & Applications

Author(s): Bann CM, Abresch RT, Biesecker B, Conway KC, Heatwole C,

Abstract Share this page

Abstract OBJECTIVES: The objectives of this study were to develop a conceptual model of quality of life (QOL) in muscular dystrophies (MDs) and review existing QOL measures for use in the MD population. METHODS: Our model for QOL among individuals with MD was developed based on a modified Delphi process, literature review, and input from patients and patient advocacy organizations. Scales that have been used to measure QOL among patients with MD were identified through a literature review and evaluated using the COSMIN (Consensus-Based Standards for the Selection of Health Measurement Instruments) checklist. RESULTS: The Comprehensive Model of QOL in MD (CMQM) captures 3 broad domains of QOL (physical, psychological, and social), includes factors influencing self-reported QOL (disease-related factors, support/resources, and expectations/aspirations), and places these concepts within the context of the life course. The literature review identified 15 QOL scales (9 adult and 6 pediatric) that have been applied to patients with MD. Very few studies reported reliability data, and none included data on responsiveness of the measures to change in disease progression, a necessary psychometric property for measures included in treatment and intervention studies. No scales captured all QOL domains identified in the CMQM model. CONCLUSIONS: Additional scale development research is needed to enhance assessment of QOL for individuals with MD. Item banking and computerized adaptive assessment would be particularly beneficial by allowing the scale to be tailored to each individual, thereby minimizing respondent burden. © 2015 American Academy of Neurology.
This article was published in Neurology and referenced in Modern Chemistry & Applications

Relevant Expert PPTs

Relevant Speaker PPTs

  • Eugene Stephane Mananga
    On Fer and Floquet-Magnus expansions: Application in solid-state nuclear magnetic resonance and physics
    PDF Version
  • Jahid Zeghiche
    Jahid-Zeghiche-Univesity-of-Al-Baha- Saudi-Arabia- Compressive- Strength-of-Concerete-filled-Thin- Steel-Stubs-Theoretical-and-Experimental-Study
    PPT Version | PDF Version
  • Yosef Yarden
    Classically, the 3’untranslated region (3’UTR) is that region in eukaryotic protein-coding genes from the translation termination codon to the polyA signal. It is transcribed as an integral part of the mRNA encoded by the gene. However, there exists another kind of RNA, which consists of the 3’UTR alone, without all other elements in mRNA such as 5’UTR and coding region. The importance of independent 3’UTR RNA (referred as I3’UTR) was prompted by results of artificially introducing such RNA species into malignant mammalian cells. Since 1991, we found that the middle part of the 3’UTR of the human nuclear factor for interleukin-6 (NF-IL6) or C/EBP gene exerted tumor suppression effect in vivo. Our subsequent studies showed that transfection of C/EBP 3’UTR led to down-regulation of several genes favorable for malignancy and to up-regulation of some genes favorable for phenotypic reversion. Also, it was shown that the sequences near the termini of the C/EBP 3’UTR were important for its tumor suppression activity. Then, the C/EBP 3’UTR was found to directly inhibit the phosphorylation activity of protein kinase CPKC in SMMC-7721, a hepatocarcinoma cell line. Recently, an AU-rich region in the C/EBP 3’UTR was found also to be responsible for its tumor suppression. Recently we have also found evidence that the independent C/EBP 3’UTR RNA is actually exists in human tissues, such as fetal liver and heart, pregnant uterus, senescent fibroblasts etc. Through 1990’s to 2000’s, world scientists found several 3’UTR RNAs that functioned as artificial independent RNAs in cancer cells and resulted in tumor suppression. Interestingly, majority of genes for these RNAs have promoter-like structures in their 3’UTR regions, although the existence of their transcribed products as independent 3’UTR RNAs is still to be confirmed. Our studies indicate that the independent 3’UTR RNA is a novel non-coding RNA species whose function should be the regulation not of the expression of their original mRNA, but of some essential life activities of the cell as a whole.
    PPT Version | PDF Version
  • Mark N. Callender
    Mark-N-Callender-Middle-Tennessee-State-University-USA-Theoretical-optimization-of-a-cylindrical-body-of-rotation-using-magnus-effect-lift
    PPT Version | PDF Version
  • Daniel Smith
    The editor as auteur: The modern role of editors and preditors
    PPT Version | PDF Version
  • Nadia Badr
    Application of aquatic plant phytoremediation as green technology treatment of lead in polluted water
    PPT Version | PDF Version
  • Olga V Shuvaeva
    The use of thermal release technique with atomic absorption detection for the study of mercury transformation in contaminated environment
    PPT Version | PDF Version
  • Abel E Navarro
    Improving the adsorptive properties of biomaterials for the removal of heavy metals
    PPT Version | PDF Version
  • Dequan Xiao
    Inverse molecular design of green catalysts for biomass conversion
    PPT Version | PDF Version
  • Shenghong A Dai
    Green processes to diisocyanates and polyurethane-urea elastomers via carbonate raw materials: New NPR and NIR processes
    PPT Version | PDF Version
  • J S Yadav
    Novel organic transformations in aqueous media
    PPT Version | PDF Version
  • Neha Singh
    Role of Hydrogeochemistry in the release of arsenic in 24 Parganas districts, West Bengal
    PPT Version | PDF Version
  • David Y Lai
    Mechanism-based molecular design of chemicals with low carcinogenicity potential
    PPT Version | PDF Version
  • Lothar Brecker
    In situ NMR and STD NMR to study mechanisms of enzyme catalyzed reactions to optimize use of enzymes in organic synthesis
    PPT Version | PDF Version
  • Rakeshwar Bandichhor
    Green Chemistry Innovation in the Synthesis of Medicines
    PPT Version | PDF Version

Recommended Conferences

Relevant Topics

Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

 
© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
adwords